Login

Dividend Policy, Acquisition Plans, Regional Expansion, Challenges, and Opportunities: A Comprehensive Outlook on Future Growth |Rob Wallace, CEO , Frasers Logistics and Commercial Trust. 00:10:00

Share On Facebook Share On Twitter

A detailed discussion covering the current dividend policy, acquisition strategies, regional expansion plans, challenges, and opportunities for growth in the foreseeable future.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
BVZ Group Half-Year Financials 2019: An Interview with Fernando Lehner, Company Leader | Fernando Lehner - CEO of bvz holding ag
00:10:00
Harnessing the Power of the Placenta: A Journey in Cellular Medicine Innovation and Preservation of Human Performance| Robert Hariri, M.D., Ph.D., CEO, Celularity Inc.
00:10:00
JCPenney Faces Challenges with Cash Flow and Customer Engagement Amid Strategy Shift
00:10:00
Empowering Efficiency: Objective Corporation's Commitment to Streamlined Solutions | Tony Walls, Chairman/CEO/Founder of Objective Corp Ltd.
00:10:00
From the Trenches to the Investment Table: A SuperAngel Story|Ben Zises,General Partner, SuperAngel.Fund
00:10:00
Brooge Energy – executive interview | Paul Ditchburn, CEO, Brooge Energy LtdBROG:NAQ
00:10:00
BlackRock Switzerland's CEO highlights how the pandemic has increased investor focus on the 'S' in ESG, while also discussing structured products for wealth managers.
00:10:00
The Global Venture Market will the VC funding decline stifle innovation|Amy Cheetham,Partner,Costanoa Ventures
00:10:00
Di-crop M.O.L.E. Method | John Kutcher, ceo at Di-Corp (TS)
00:10:00
Dish and EchoStar chairman Charlie Ergen, alongside EchoStar CEO Hamid Akhavan, join 'Squawk on the Street' to discuss Ergen's rationale behind the decision to merge.|Hamid Akhavan is the President and CEO of DISH and EchoStar
00:10:00
Rebranding for the Future: Bernard Fick and Graham Mason on Becoming M&G Investments
00:10:00
Phost's Breakthrough in Neurodegenerative Disease Treatment: CEO Michael Thern on Accelerated FDA Approval for Monipentel|Dr Michael Thurn,Managing Director & Chief Executive Officer,PharmAust Ltd.

© 2017 - Townhall + Tv